| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aquestive Therapeutics, Inc. | Director | Common Stock | 31,635 | $25,624 | $0.8100 | 15 Jun 2021 | Direct |
| Matinas BioPharma Holdings, Inc. | Director | Stock option (right to buy) | 437,244 | 01 Nov 2023 | Direct | ||
| Aquestive Therapeutics, Inc. | Director | Stock Option (Right to Purchase) | 20,000 | 15 Jun 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MTNB | Matinas BioPharma Holdings, Inc. | 01 Nov 2023 | 1 | $0 | 4 | Director | 03 Nov 2023, 16:49 |
| MTNB | Matinas BioPharma Holdings, Inc. | 14 Nov 2022 | 1 | $0 | 4 | Director | 16 Nov 2022, 20:31 |
| MTNB | Matinas BioPharma Holdings, Inc. | 01 Nov 2021 | 1 | $0 | 4 | Director | 02 Nov 2021, 16:18 |
| MTNB | Matinas BioPharma Holdings, Inc. | 19 Jun 2021 | 3 | $0 | 4 | Director | 24 Jun 2021, 17:46 |
| AQST | Aquestive Therapeutics, Inc. | 15 Jun 2021 | 1 | $0 | 4 | Director | 17 Jun 2021, 18:51 |